• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物可利用的乳酸菌和双歧杆菌产生的胞外多糖作为发酵底物。

Exopolysaccharides Produced by Lactic Acid Bacteria and Bifidobacteria as Fermentable Substrates by the Intestinal Microbiota.

机构信息

a Department of Microbiology and Biochemistry of Dairy Products , Instituto de Productos Lácteos de Asturias - Consejo Superior de Investigaciones Científicas (IPLA-CSIC) , Villaviciosa , Asturias , Spain.

出版信息

Crit Rev Food Sci Nutr. 2016 Jul 3;56(9):1440-53. doi: 10.1080/10408398.2013.770728.

DOI:10.1080/10408398.2013.770728
PMID:25675369
Abstract

The functional food market, including products formulated to maintain a "healthy" gut microbiota, i.e. probiotics and prebiotics, has increased enormously since the end of the last century. In order to favor the competitiveness of this sector, as well as to increase our knowledge of the mechanisms of action upon human health, new probiotic strains and prebiotic substrates are being studied. This review discusses the use of exopolysaccharides (EPS), both homopolysaccharides (HoPS) and heteropolysaccharides (HePS), synthesized by lactic acid bacteria and bifidobacteria as potential prebiotics. These extracellular carbohydrate polymers synthesized by some gut inhabitants seem to be resistant to gastrointestinal digestion; these are susceptible as well to biodegradability by the intestinal microbiota depending on both the physicochemical characteristics of EPS and the pool of glycolytic enzymes harbored by microbiota. Therefore, although the chemical composition of these HoPS and HePS is different, both can be fermentable substrates by intestinal inhabitants and good candidates as prebiotic substrates. However, there are limitations for their use as additives in the food industry due to, on the one hand, their low production yield and, on the other hand, a lack of clinical studies demonstrating the functionality of these biopolymers.

摘要

自上个世纪末以来,功能性食品市场(包括旨在维持“健康”肠道微生物群的产品,即益生菌和益生元)大幅增长。为了提高该行业的竞争力,以及增加我们对这些益生菌和益生元作用机制的了解,正在研究新的益生菌菌株和益生元底物。本文综述了由乳酸菌和双歧杆菌合成的胞外多糖(EPS),包括同多糖(HoPS)和杂多糖(HePS),作为潜在的益生元的用途。这些由一些肠道居民合成的细胞外碳水化合物聚合物似乎能抵抗胃肠道消化;它们也可能会被肠道微生物群的生物降解,这取决于 EPS 的理化特性和微生物群中糖酵解酶的库。因此,尽管这些 HoPS 和 HePS 的化学成分不同,但它们都可以作为肠道居民的可发酵底物,是很好的益生元底物候选物。然而,由于其生产产量低,并且缺乏临床研究证明这些生物聚合物的功能性,因此它们在食品工业中的应用存在局限性。

相似文献

1
Exopolysaccharides Produced by Lactic Acid Bacteria and Bifidobacteria as Fermentable Substrates by the Intestinal Microbiota.肠道微生物可利用的乳酸菌和双歧杆菌产生的胞外多糖作为发酵底物。
Crit Rev Food Sci Nutr. 2016 Jul 3;56(9):1440-53. doi: 10.1080/10408398.2013.770728.
2
Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.长双歧杆菌 IPLA E44 和动物双歧杆菌亚种。乳双歧杆菌 IPLA R1 产生的胞外多糖改变了 pH 控制批次培养中人体粪便微生物群的组成和代谢活性。
Int J Food Microbiol. 2009 Nov 15;135(3):260-7. doi: 10.1016/j.ijfoodmicro.2009.08.017. Epub 2009 Aug 19.
3
Production of exopolysaccharides by Lactobacillus and Bifidobacterium strains of human origin, and metabolic activity of the producing bacteria in milk.源自人类的乳酸杆菌和双歧杆菌菌株胞外多糖的产生以及产糖细菌在牛奶中的代谢活性。
J Dairy Sci. 2009 Sep;92(9):4158-68. doi: 10.3168/jds.2009-2126.
4
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria.肠道双歧杆菌菌株产生的胞外多糖可作为人类肠道细菌的可发酵底物。
Appl Environ Microbiol. 2008 Aug;74(15):4737-45. doi: 10.1128/AEM.00325-08. Epub 2008 Jun 6.
5
Antigenotoxic activity of lactic acid bacteria, prebiotics, and products of their fermentation against selected mutagens.乳酸菌、益生元及其发酵产物对特定诱变剂的抗遗传毒性活性。
Regul Toxicol Pharmacol. 2015 Dec;73(3):938-46. doi: 10.1016/j.yrtph.2015.09.021. Epub 2015 Sep 25.
6
Effects of bifidobacteria-produced exopolysaccharides on human gut microbiota in vitro.双歧杆菌胞外多糖对体外人体肠道微生物群的影响。
Appl Microbiol Biotechnol. 2019 Feb;103(4):1693-1702. doi: 10.1007/s00253-018-9572-6. Epub 2018 Dec 19.
7
Advances in production and simplified methods for recovery and quantification of exopolysaccharides for applications in food and health.用于食品和健康领域的胞外多糖生产进展以及回收和定量的简化方法。
J Dairy Sci. 2016 Apr;99(4):3229-3238. doi: 10.3168/jds.2015-9936. Epub 2016 Feb 10.
8
Genetic mechanisms of prebiotic oligosaccharide metabolism in probiotic microbes.益生菌微生物中前生物寡糖代谢的遗传机制。
Annu Rev Food Sci Technol. 2015;6:137-56. doi: 10.1146/annurev-food-022814-015706. Epub 2014 Dec 19.
9
Metabolism by bifidobacteria and lactic acid bacteria of polysaccharides from wheat and rye, and exopolysaccharides produced by Lactobacillus sanfranciscensis.双歧杆菌和乳酸菌对小麦和黑麦多糖以及旧金山乳杆菌产生的胞外多糖的代谢作用。
J Appl Microbiol. 2002;92(5):958-65. doi: 10.1046/j.1365-2672.2002.01607.x.
10
Bacteroides fragilis metabolises exopolysaccharides produced by bifidobacteria.脆弱拟杆菌代谢双歧杆菌产生的胞外多糖。
BMC Microbiol. 2016 Jul 15;16(1):150. doi: 10.1186/s12866-016-0773-9.

引用本文的文献

1
Effect of Homogenization and Pectin on Chemical, Textural, Antioxidant and Sensory Characteristics of -Fermented Oat-Based Product.均质化和果胶对基于燕麦发酵产品的化学、质地、抗氧化和感官特性的影响。
Foods. 2025 Jul 25;14(15):2615. doi: 10.3390/foods14152615.
2
Bifidobacteria in antibiotic-associated dysbiosis: restoring balance in the gut microbiome.抗生素相关性菌群失调中的双歧杆菌:恢复肠道微生物群的平衡
World J Microbiol Biotechnol. 2025 Aug 6;41(8):297. doi: 10.1007/s11274-025-04517-1.
3
The Role of Microbial Exopolysaccharides in Preventing and Treating Cardiovascular Diseases.
微生物胞外多糖在预防和治疗心血管疾病中的作用
Microorganisms. 2025 Jun 29;13(7):1522. doi: 10.3390/microorganisms13071522.
4
The role of teichoic acids of bifidobacteria in driving the interaction with the human host.双歧杆菌的磷壁酸在推动与人类宿主相互作用中的作用。
Front Microbiol. 2025 Jul 10;16:1616397. doi: 10.3389/fmicb.2025.1616397. eCollection 2025.
5
Protective Effects of Ginseng Soluble Dietary Fiber and Its Fecal Microbiota Extract on Antibiotic-Induced Gut Dysbiosis Obese Mice.人参可溶性膳食纤维及其粪便微生物群提取物对抗生素诱导的肥胖小鼠肠道菌群失调的保护作用。
J Microbiol Biotechnol. 2025 Jul 14;35:e2502013. doi: 10.4014/jmb.2502.02013.
6
Safety and Probiotics Evaluation of Bifidobacterial Genomes Isolated from Probiotic Products.从益生菌产品中分离出的双歧杆菌基因组的安全性及益生菌评估
Curr Microbiol. 2025 Apr 17;82(6):246. doi: 10.1007/s00284-025-04139-8.
7
Lactic Acid Bacteria Exopolysaccharides Unveiling Multifaceted Insights from Structure to Application in Foods and Health Promotion.乳酸菌胞外多糖:揭示从结构到在食品及健康促进方面应用的多层面见解
Foods. 2025 Feb 27;14(5):823. doi: 10.3390/foods14050823.
8
Biological Activity of Lactic Acid Bacteria Exopolysaccharides and Their Applications in the Food and Pharmaceutical Industries.乳酸菌胞外多糖的生物活性及其在食品和制药工业中的应用
Foods. 2024 May 23;13(11):1621. doi: 10.3390/foods13111621.
9
exopolysaccharides: new insights into engineering strategies, physicochemical functions, and immunomodulatory effects on host health.胞外多糖:工程策略、物理化学功能及对宿主健康的免疫调节作用的新见解
Front Microbiol. 2024 May 6;15:1396308. doi: 10.3389/fmicb.2024.1396308. eCollection 2024.
10
Marine Pediococcus pentosaceus E3 Probiotic Properties, Whole-Genome Sequence Analysis, and Safety Assessment.海洋戊糖片球菌 E3 益生菌特性、全基因组序列分析及安全性评估。
Probiotics Antimicrob Proteins. 2024 Dec;16(6):1925-1936. doi: 10.1007/s12602-024-10283-7. Epub 2024 May 15.